NCT00005984 arm group afbcf758f88a424f9450463f84defc66 [clinicaltrials_resource:NCT00005984/arm-group/afbcf758f88a424f9450463f84defc66]
cyclophosphamide [clinicaltrials_resource:29b86e6efc24e2ac8cce73ed3dd0cbd8]filgrastim [clinicaltrials_resource:6af08cf93264e32579f8f03ac2ff59ce]radiation therapy [clinicaltrials_resource:6cffff29d6ab6006e769fdd4a24bb432]recombinant interferon alfa [clinicaltrials_resource:bb99552d707c437ce0320971608115ee]peripheral blood stem cell transplantation [clinicaltrials_resource:c03b88525b5d0a20e7a9c9173707a3a0]clinicaltrials:NCT00005984
arm group [clinicaltrials_vocabulary:arm-group]
NCT00005984 arm group afbcf758f88a424f9450463f84defc66 [clinicaltrials_resource:NCT00005984/arm-group/afbcf758f88a424f9450463f84defc66]
Bio2RDF identifier
NCT00005984/arm-group/afbcf758f88a424f9450463f84defc66
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... bcf758f88a424f9450463f84defc66
description [clinicaltrials_vocabulary:description]
Patients treated for chronic accelerated phase and/or chronic myelogenous leukemia (CML)
identifier
clinicaltrials_resource:NCT00005984/arm-group/afbcf758f88a424f9450463f84defc66
title
NCT00005984 arm group afbcf758f88a424f9450463f84defc66
@en
type
label
NCT00005984 arm group afbcf758 ...... cf758f88a424f9450463f84defc66]
@en